According to Italian data, people who inject drugs (PWID) have high prevalence of
Hepatitis C Virus (HCV) infection (30-60%). PWID have inadequate access to directly
acting antivirals (DAA) due to (1) their mistrust towards the healthcare system and
(2) the lack of coordination between medical specialists who play a pivotal role in
the diagnosis and treatment of HCV infection. We aim to describe the HCV -treatment
cascade of care in Trieste on PWID.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Digestive and Liver DiseaseAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2019 Published by Elsevier Inc.
